ORIC Pharmaceuticals, Inc. (ORIC) Tops Q1 EPS by 9c

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q1 EPS of ($0.42), $0.09 better than the analyst estimate of ($0.51).

For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.

You May Also Be Interested In

• Rockstar Energy founder seeks CEO role at Celsius Holdings
• Chevron Sees Lower End Of $18-$19B Capex Guidance At Yr End - Bloomberg
• Hawaiian Electric Industries (HE) Misses Q2 EPS by 6c